Brg-1 Monoclonal Antibody

The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene.

Introducing the BRG-1 Monoclonal Antibody, a cutting-edge biotechnological innovation designed to revolutionize the field of immunology. This meticulously crafted product is the result of extensive research and development, aimed at providing scientists and researchers with a powerful tool to advance their studies in the realm of cellular biology.

The BRG-1 Monoclonal Antibody is meticulously engineered to specifically target and bind to the BRG-1 protein, a key regulator of chromatin remodeling and gene expression. With its exceptional specificity and high affinity, this antibody enables precise detection and analysis of BRG-1 in various biological samples, facilitating a deeper understanding of its role in cellular processes.

Crafted with utmost precision, the BRG-1 Monoclonal Antibody exhibits exceptional performance characteristics. Its superior sensitivity ensures accurate detection even at low concentrations, while its robust stability guarantees consistent results over time. This antibody's exceptional specificity minimizes cross-reactivity, ensuring reliable and reproducible data.

The BRG-1 Monoclonal Antibody is designed to cater to the diverse needs of researchers across various scientific disciplines. Its versatility allows for a wide range of applications, including immunohistochemistry, western blotting, and chromatin immunoprecipitation. This adaptability empowers scientists to explore the intricate mechanisms underlying gene regulation and chromatin remodeling, paving the way for groundbreaking discoveries.

In addition to its exceptional performance, the BRG-1 Monoclonal Antibody is manufactured in strict compliance with rigorous quality control standards. Each batch undergoes meticulous testing to ensure consistency, reliability, and reproducibility. This commitment to quality guarantees that researchers can rely on this antibody to deliver accurate and dependable results, time and time again.

The BRG-1 Monoclonal Antibody represents a significant advancement in the field of immunology, offering researchers an invaluable tool to unravel the complexities of cellular biology. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to revolutionize scientific investigations and drive groundbreaking discoveries in the realm of gene regulation and chromatin remodeling.